| KOTAK MANUFACTURE IN INDIA FUND
An open ended equity scheme following manufacturing theme
| KOTAK MANUFACTURE IN INDIA FUND
An open ended equity scheme following manufacturing theme

      

      
Investment Objective

The scheme shall seek to generate capital appreciation by investing in a diversified portfolio of companies that follow the manufacturing theme.
However, there is no assurance that the objective of the Scheme will be realized

The scheme shall seek to generate capital appreciation by investing in a diversified portfolio of companies that follow the manufacturing theme.
However, there is no assurance that the objective of the Scheme will be realized

Issuer/Instrument Industry/
Rating
% to Net
Assets

Equity & Equity related
Pharmaceuticals & Biotechnology 15.19
Sun Pharmaceuticals Industries Ltd. 4.54
Dr Reddys Laboratories Ltd. 3.32
Cipla Ltd. 2.88
Gland Pharma Limited 2.24
Zydus Lifesciences Limited 2.21
Automobiles 13.39
Maruti Suzuki India Limited 5.93
Mahindra & Mahindra Ltd. 4.18
Tata Motors Ltd. 1.99
Eicher Motors Ltd. 1.29
Consumer Durables 9.39
Bata India Ltd. 2.04
Whirlpool of India Ltd. 1.70
Voltas Ltd. 1.50
V-Guard Industries Ltd. 1.48
Kajaria Ceramics Ltd. 1.44
Dixon Technologies India Ltd. 1.23
Petroleum Products 9.31
Reliance Industries Ltd. 7.79
Bharat Petroleum Corporation Ltd. 1.52
Industrial Products 8.66
Carborundum Universal Ltd. 2.14
Bharat Forge Ltd. 1.96
AIA Engineering Limited. 1.76
Cummins India Ltd. 1.44
Supreme Industries Limited 1.36
Auto Components 5.64
Schaeffler India Ltd 2.42
Motherson Sumi Systems Ltd. 2.02
Balkrishna Industries Ltd. 1.20
Electrical Equipment 4.12
ABB India Ltd 2.20
Thermax Ltd. 1.92
Fertilizers & Agrochemicals 3.86
P I Industries Ltd 1.99
Coromandel International Ltd. 1.87
Non - Ferrous Metals 3.71
Hindalco Industries Ltd 3.71
Ferrous Metals 2.75
Tata Steel Ltd. 2.75
Construction 2.37
Larsen And Toubro Ltd. 2.37
Chemicals & Petrochemicals 2.29
SRF Ltd. 1.23
Solar Industries India Limited 1.06
Cement & Cement Products 2.08
Ultratech Cement Ltd. 2.08
Agricultural, Commercial & Construction Vehicles 1.77
Ashok Leyland Ltd. 1.77
Beverages 1.77
United Breweries Ltd. 1.77
Aerospace & Defense 1.67
Bharat Electronics Ltd. 1.67
Personal Products 1.64
Godrej Consumer Products Ltd. 1.64
Diversified 1.11
3M India Ltd. 1.11
Textiles & Apparels 0.69
Garware Technical Fibres Ltd. 0.69
Equity & Equity related - Total 91.41
Mutual Fund Units
Kotak Liquid Scheme Direct Plan Growth 5.27
Mutual Fund Units - Total 5.27
Triparty Repo 4.12
Net Current Assets/(Liabilities) -0.80
Grand Total 100.00



NAV
Reg-Plan-IDCWRs10.4880
Dir-Plan-IDCWRs10.5230
Growth optionRs10.4880
Direct Growth optionRs10.5230

Available Plans/Options

A) Regular Plan B) Direct Plan
Options: Growth and Income Distribution cum capital withdrawal (IDCW) (Payout and Reinvestment) (applicable for all plans)


Fund Manager Mr.Harish Krishnan, Mr. Abhishek Bisen*
Benchmark Nifty India Manufacturing Index TRI
Allotment dateFebruary 22, 2022
AAUMRs709.43 crs
AUMRs716.22 crs
Folio count36,546

IDCW Frequency

Trustee's Discretion

Source: $ ICRA MFI Explorer.


Minimum Investment Amount

Initial Investment: Rs5000 and in multiple ofRs1 for purchase and of Rs0.01 for switches
Additional Investment: Rs1000 & in multiples of Rs1 for purchase and for Rs0.01 for switches
Ideal Investments Horizon: 5 years & above


Load Structure

Entry Load: Nil. (applicable for all plans)
Exit Load: a)For redemption / switch out of upto 10% of the initial investment amount (limit) purchased or switched in within 1 year from the date of allotment: Nil.
b)If units redeemed or switched out are excess of the limit within 1 year from the date of allotment: 1%
c)If units are redeemed or switched out or after 1 year from the date of allotment: NIL
Units issued on reinvestment of IDCW shall not be subject to entry and exit load.


Total Expense Ratio**

Regular: 2.42%; Direct: 0.67%


Data as on April 30, 2022

Fund


Benchmark
This product is suitable for investors who are seeking*:
  • Long-term capital growth
  • Investment equity and equity related securities across market capitalisation.

* Investors should consult their financial advisers if in doubt about whether the product is suitable for them.

Scheme has not completed 6 months since inception
**Total Expense Ratio includes applicable B30 fee and GST.
* For Fund Manager experience, please refer 'Our Fund Managers'